PKM and diabetic kidney disease: While these studies identify PKM2 as a significant contributor to the pathogenesis of diabetic nephropathy and support the therapeutic potential of pharmacological activators of PKM2 in preventing kidney injury, other studies demonstrated a potential nephroprotective effect of PKM2 pharmacological inhibition.